RSV vaccine competition heats up as Pfizer’s shot for older adults gets FDA approval

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 46 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 97%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

The Food and Drug Administration approved Pfizer’s RSV vaccine for older adults – just weeks after the agency gave the green light to the first RSV shot for use in the U.S. Global market for RSV vaccines could reach $17 billion by 2033.

The race to grab a piece of a fast-growing market for respiratory-disease vaccines intensified this week as the Food and Drug Administration on Wednesday approved Pfizer’s PFE, -0.01% Abrysvo, a respiratory syncytial virus vaccine for older adults.

RSV often causes only mild coldlike symptoms, but it can also lead to lung infections or pneumonia. Up to 160,000 older adults are hospitalized and up to 10,000 die each year due to RSV infection, according to the Centers for Disease Control and Prevention. Adults age 65 and older and those with chronic heart or lung disease or weakened immune systems are at highest risk, according to the CDC.

More competition is on the horizon, with Moderna MRNA, +0.21% expected to launch an RSV vaccine next year. In a clinical trial, Pfizer’s RSV vaccine for older adults was 67% effective against lower-respiratory-tract illness with at least two signs or symptoms and 86% effective against illness with at least three signs or symptoms. In February, an FDA advisory panel narrowly backed the shot, with some panelists raising concerns about Guillain-Barre syndrome, a rare neurological reaction.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Vatican questions how priest moved $17 million meant for missionary work into investment fundPope Francis has asked aides to get to the bottom of how at least $17 million was transferred from the Vatican’s U.S.-based missionary fundraising coffers into an impact investing vehicle run by a priest. The story of what happened to the money and how is one that has vexed Vatican officials on both sides of the Atlantic for over two years, all the more because it appears the transfers were completely legal. But they have nevertheless prompted the new leadership of the Vatican’s missionary fundraising operation in the U.S., The Pontifical Mission Societies, to fire the staff and board of directors who approved them, and overhaul its bylaws and statutes, to make sure nothing like this ever happens again.
Source: AP - 🏆 728. / 51 Read more »